3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Conditions
Sarcoma
2
Uterine Cervical Neoplasms
1
Skin Neoplasms
1
Neoplasm Metastasis
1
Leiomyosarcoma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
5
Specimen Handling
5
Nivolumab
5
Cyclophosphamide
5
Magnetic Resonance Spectroscopy
4
Bevacizumab
4
Oxaliplatin
3
Leucovorin
3
Cisplatin
3
sargramostim
2
fludarabine
2
cabozantinib
2
aflibercept
2
X-Rays
2
Stem Cell Transplantation
2
Sirolimus
2
Paclitaxel
2
Mesna
2
Melphalan
2
Irinotecan
2
Ipilimumab
2
Ifosfamide
2
Fluorouracil
2
Fluorodeoxyglucose F18
2
Filgrastim
2
Etoposide
2
Erlotinib Hydrochloride
2
Doxorubicin
2
Cryosurgery
2
Busulfan
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Tissue Banks
×
Sarcoma
×
Clear all
NCT06349642
2026-03-12
ELEPHAS-04
Mayo Clinic
Recruiting
324 enrolled